Shmt2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma

HIGHLIGHTS

• who: Weiyu Kong from the Center for Biotechnology Information to validate theHôpital Foch, France Virginia Commonwealth University have published the article: SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma, in the Journal: (JOURNAL)
• what: This study demonstrated that SHMT2 could promote the infiltration of Treg cells and mediate immune escape.
• how: Response prediction of anti-tumour drugs To evaluate SHMT2 for pRCC treatment the IC50 of commonly administered anti-tumour drugs in the TCGA project of the pRCC dataset was calculated using the algorithm developed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.